Katsuki A - Search Results

1

Efficacy, Tolerability, and Safety of Blonanserin in Schizophrenia: An Updated and Extended Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Kishi T, Matsui Y, Matsuda Y, Katsuki A, Hori H, Yanagimoto H, Sanada K, Morita K, Yoshimura R, Shoji Y, Hagi K, Iwata N. Kishi T, et al. Among authors: katsuki a. Pharmacopsychiatry. 2019 Feb;52(2):52-62. doi: 10.1055/a-0574-0088. Epub 2018 Mar 7. Pharmacopsychiatry. 2019. PMID: 29514360

2

The cognitive profile of aripiprazole differs from that of other atypical antipsychotics in schizophrenia patients.

Hori H, Yoshimura R, Katsuki A, Hayashi K, Ikenouchi-Sugita A, Umene-Nakano W, Nakamura J. Hori H, et al. Among authors: katsuki a. J Psychiatr Res. 2012 Jun;46(6):757-61. doi: 10.1016/j.jpsychires.2012.02.013. Epub 2012 Mar 29. J Psychiatr Res. 2012. PMID: 22464338

3

Comparison of the efficacy between paroxetine and sertraline augmented with aripiprazole in patients with refractory major depressive disorder.

Yoshimura R, Kishi T, Hori H, Ikenouchi-Sugita A, Katsuki A, Umene-Nakano W, Iwata N, Nakamura J. Yoshimura R, et al. Among authors: katsuki a. Prog Neuropsychopharmacol Biol Psychiatry. 2012 Dec 3;39(2):355-7. doi: 10.1016/j.pnpbp.2012.07.008. Epub 2012 Jul 17. Prog Neuropsychopharmacol Biol Psychiatry. 2012. PMID: 22813840 Clinical Trial.

4

Switching to antipsychotic monotherapy can improve attention and processing speed, and social activity in chronic schizophrenia patients.

Hori H, Yoshimura R, Katsuki A, Sugita AI, Atake K, Nakamura J. Hori H, et al. Among authors: katsuki a. J Psychiatr Res. 2013 Dec;47(12):1843-8. doi: 10.1016/j.jpsychires.2013.08.024. Epub 2013 Sep 7. J Psychiatr Res. 2013. PMID: 24054464 Clinical Trial.

5

Effect of blonanserin on cognitive and social function in acute phase Japanese schizophrenia compared with risperidone.

Hori H, Yamada K, Kamada D, Shibata Y, Katsuki A, Yoshimura R, Nakamura J. Hori H, et al. Among authors: katsuki a. Neuropsychiatr Dis Treat. 2014 Mar 26;10:527-33. doi: 10.2147/NDT.S59861. eCollection 2014. Neuropsychiatr Dis Treat. 2014. PMID: 24707178 Free PMC article.

6

Marked Improvement of Meige Syndrome in a Japanese Male Patient with Schizophrenia After Switching from Risperidone to Paliperidone: A Case Report.

Yoshimura R, Hori H, Katsuki A, Atake K. Yoshimura R, et al. Among authors: katsuki a. J UOEH. 2016 Sep;38(3):233-6. doi: 10.7888/juoeh.38.233. J UOEH. 2016. PMID: 27627971 Free article.

7

Effects of Continuing Oral Risperidone vs. Switching from Risperidone to Risperidone Long-Acting Injection on Cognitive Function in Stable Schizophrenia Patients: A Pilot Study.

Hori H, Katsuki A, Atake K, Yoshimura R. Hori H, et al. Among authors: katsuki a. Front Psychiatry. 2018 Mar 8;9:74. doi: 10.3389/fpsyt.2018.00074. eCollection 2018. Front Psychiatry. 2018. PMID: 29568276 Free PMC article.

8

Plasma levels of 3-methoxy-4-hydroxyphenylglycol levels, number of hospitalization and cognitive function predicts the cognitive effect of atypical antipsychotic monotherapy in patients with acute schizophrenia.

Hori H, Yoshimura R, Katsuki A, Atake K. Hori H, et al. Among authors: katsuki a. Int Clin Psychopharmacol. 2020 Mar;35(2):89-97. doi: 10.1097/YIC.0000000000000293. Int Clin Psychopharmacol. 2020. PMID: 31743230

9

Several prescription patterns of antipsychotic drugs influence cognitive functions in Japanese chronic schizophrenia patients.

Hori H, Yoshimura R, Katsuki A, Hayashi K, Ikenouchi-Sugita A, Umene-Nakano W, Nakamura J. Hori H, et al. Among authors: katsuki a. Int J Psychiatry Clin Pract. 2012 Jun;16(2):138-42. doi: 10.3109/13651501.2011.631018. Epub 2011 Dec 5. Int J Psychiatry Clin Pract. 2012. PMID: 22136174

10

Adding a low dose atypical antipsychotic drug to an antidepressant induced a rapid increase of plasma brain-derived neurotrophic factor levels in patients with treatment-resistant depression.

Yoshimura R, Ikenouchi-Sugita A, Hori H, Umene-Nakano W, Katsuki A, Hayashi K, Ueda N, Nakamura J. Yoshimura R, et al. Among authors: katsuki a. Prog Neuropsychopharmacol Biol Psychiatry. 2010 Mar 17;34(2):308-12. doi: 10.1016/j.pnpbp.2009.12.003. Epub 2009 Dec 11. Prog Neuropsychopharmacol Biol Psychiatry. 2010. PMID: 20005280

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

156 results

Search Page